We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 195

Insights conversations: life sciences

  • Skadden Arps Slate Meagher & Flom LLP
  • -
  • USA
  • -
  • January 27 2015

A healthy market for M&A activity, particularly cross-border deals, and a strict regulatory environment are the big factors influencing the health

Affordable Care Act considerations in mergers and acquisitions

  • Drinker Biddle & Reath LLP
  • -
  • USA
  • -
  • December 19 2014

With the passage of the Patient Protection and Affordable Care Act (ACA) in 2010 and the potential imposition of significant penalties, companies

The unique risks of investing in out-of-network providers

  • McGuireWoods LLP
  • -
  • USA
  • -
  • December 10 2014

For several years, industry observers have been predicting the demise of out-of-network business models, yet they still survive. For some providers

October digital health investments dominated by diagnostics and therapeutics

  • Fenwick & West LLP
  • -
  • USA
  • -
  • December 2 2014

Digital health companies raised just over $730 million through venture, private equity and angel investments in September, according to our latest

The direction of the market

  • Weil Gotshal & Manges LLP
  • -
  • USA
  • -
  • November 30 2014

In a year where global M&A activity has boomed, the health care sector has emerged as one of the hottest industries for deal making, with over $400

Digital health investment in September tops $700 million

  • Fenwick & West LLP
  • -
  • USA
  • -
  • November 5 2014

Digital health companies raised just over $730 million through venture, private equity and angel investments in September, according to our latest

Mobile health technologies rake in largest digital health investments of August

  • Fenwick & West LLP
  • -
  • USA
  • -
  • September 22 2014

The top five digital health investments in August accounted for nearly half of the venture, private equity and angel investments in the sector during

Tech investors eye healthcare data firms

  • McGuireWoods LLP
  • -
  • USA
  • -
  • September 18 2014

Technology investors, including VC firms and portfolio managers of large mutual funds, are increasingly targeting healthcare data firms as new

Digital health investments dominated by software plays in July

  • Fenwick & West LLP
  • -
  • USA
  • -
  • September 8 2014

Healthcare software dominates the list of top digital health investments in July. Of the 10 digital health companies that received venture, private

Is Valeant’s offer for Allergan the new roadmap for biopharma acquisitions?

  • Kaye Scholer LLP
  • -
  • USA
  • -
  • August 22 2014

Earlier this year, Valeant Pharmaceuticals International, Inc. teamed up with the hedge fund Pershing Square Capital Management, L.P. To acquire